Aims In this study, we analyze the challenges involved in detecting novel neuraminidase inhibitors (NAIs) and offer strategies to overcome them with complementary bioassays. Materials & Methods We ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window With avian ...

Dr. Greg Poland answers the question: 'What AreTamiflu And Relenza?' May 27, 2009 -- Question:What are Tamiflu and Relenza? Answer:There are two different antiviral medications that can be used to ...

Please provide your email address to receive an email when new articles are posted on . Since May 2023, a combination of neuraminidase mutations has been detected in influenza A(H1N1)pdm09 viruses.

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and mortality. Current antiviral therapies, such as neuraminidase inhibitors and ...

The U.S. Food and Drug Administration has approved Rapivab to treat flu infections in adults, the first neuraminidase inhibitor approved for intravenous administration. The drug is intended for ...

Human parainfluenza viruses are a major cause of respiratory infections that particularly affect young children and immunocompromised individuals. These viruses present a significant global health ...